The Verdict is Out: Trials Advance Ebola Vaccine [Image 1 of 2]

FORT BELVOIR, VA, UNITED STATES

03.15.2018

Courtesy Photo

Defense Threat Reduction Agency's Chemical and Biological Technologies Department

Amy Shurtleff, Ph.D., works in a biosafety level 4 laboratory at USAMRIID.
Shurtleff is part of a team that evaluated the protective efficacy of Merck's
EBOV vaccine, V920. (Image courtesy of USAMRIID)

• Date Taken: 03.15.2018
• Date Posted: 03.15.2018 12:15
• Photo ID: 4219282
• VIRIN: 180315-A-AB123-001
• Resolution: 1200x1800
• Size: 604.44 KB
• Location: FORT BELVOIR, VA, US